Company Filing History:
Years Active: 2025
Title: Jae Ill Kim: Innovator in Heterocyclic Compounds
Introduction
Jae Ill Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel heterocyclic compounds. His work focuses on creating drugs that target diseases associated with the STAT3 protein.
Latest Patents
Jae Ill Kim holds 1 patent for his invention titled "Heterocyclic derivatives and use thereof." This patent relates to innovative heterocyclic compounds that are useful in preparing drugs for the prevention or treatment of various diseases. These diseases include solid tumors, blood cancers, radiation or drug-resistant cancers, metastatic cancers, inflammatory diseases, immune system diseases, diabetes, macular degeneration, papillomavirus infections, and tuberculosis.
Career Highlights
Jae Ill Kim is affiliated with C&C Research Laboratories, where he continues to advance his research in drug development. His work has the potential to impact the treatment of several serious health conditions, showcasing his dedication to improving patient outcomes through innovative solutions.
Collaborations
Some of his notable coworkers include Chan Hee Park and Jun Hwan Im. Their collaborative efforts contribute to the ongoing research and development initiatives at C&C Research Laboratories.
Conclusion
Jae Ill Kim is a dedicated inventor whose work in heterocyclic compounds holds promise for the future of drug development. His contributions are vital in the fight against various diseases, and his innovative spirit continues to inspire advancements in the field.